ICON PE Ratio 2010-2025 | ICLR
Current and historical p/e ratio for ICON (ICLR) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ICON PE ratio as of July 29, 2025 is 14.74.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ICON PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-29 | 185.21 | 20.18 | |
| 2025-03-31 | 174.99 | $9.18 | 19.06 |
| 2024-12-31 | 209.71 | $9.53 | 22.01 |
| 2024-09-30 | 287.31 | $8.97 | 32.03 |
| 2024-06-30 | 313.47 | $8.58 | 36.53 |
| 2024-03-31 | 335.95 | $8.22 | 40.87 |
| 2023-12-31 | 283.07 | $7.38 | 38.36 |
| 2023-09-30 | 246.25 | $6.20 | 39.72 |
| 2023-06-30 | 250.20 | $6.17 | 40.55 |
| 2023-03-31 | 213.59 | $6.18 | 34.56 |
| 2022-12-31 | 194.25 | $6.13 | 31.69 |
| 2022-09-30 | 183.78 | $5.63 | 32.64 |
| 2022-06-30 | 216.70 | $2.52 | 85.99 |
| 2022-03-31 | 243.22 | $2.49 | 97.68 |
| 2021-12-31 | 309.70 | $2.95 | 104.98 |
| 2021-09-30 | 262.02 | $3.93 | 66.67 |
| 2021-06-30 | 206.71 | $6.82 | 30.31 |
| 2021-03-31 | 196.37 | $6.34 | 30.97 |
| 2020-12-31 | 194.98 | $6.14 | 31.76 |
| 2020-09-30 | 191.09 | $6.00 | 31.85 |
| 2020-06-30 | 168.46 | $6.00 | 28.08 |
| 2020-03-31 | 136.00 | $6.79 | 20.03 |
| 2019-12-31 | 172.23 | $6.80 | 25.33 |
| 2019-09-30 | 147.34 | $6.66 | 22.12 |
| 2019-06-30 | 153.97 | $6.48 | 23.76 |
| 2019-03-31 | 136.58 | $6.10 | 22.39 |
| 2018-12-31 | 129.21 | $5.89 | 21.94 |
| 2018-09-30 | 153.75 | $5.57 | 27.60 |
| 2018-06-30 | 132.53 | $5.38 | 24.63 |
| 2018-03-31 | 118.14 | $5.26 | 22.46 |
| 2017-12-31 | 112.15 | $5.13 | 21.86 |
| 2017-09-30 | 113.88 | $5.16 | 22.07 |
| 2017-06-30 | 97.79 | $4.94 | 19.80 |
| 2017-03-31 | 79.72 | $4.89 | 16.30 |
| 2016-12-31 | 75.20 | $4.72 | 15.93 |
| 2016-09-30 | 77.37 | $4.50 | 17.19 |
| 2016-06-30 | 70.01 | $4.39 | 15.95 |
| 2016-03-31 | 75.10 | $4.20 | 17.88 |
| 2015-12-31 | 77.70 | $3.98 | 19.52 |
| 2015-09-30 | 70.97 | $3.74 | 18.98 |
| 2015-06-30 | 67.30 | $3.51 | 19.17 |
| 2015-03-31 | 70.53 | $3.20 | 22.04 |
| 2014-12-31 | 50.99 | $2.87 | 17.77 |
| 2014-09-30 | 57.23 | $2.53 | 22.62 |
| 2014-06-30 | 47.11 | $2.19 | 21.51 |
| 2014-03-31 | 47.55 | $1.91 | 24.90 |
| 2013-12-31 | 40.42 | $1.65 | 24.49 |
| 2013-09-30 | 40.93 | $1.46 | 28.03 |
| 2013-06-30 | 35.43 | $1.30 | 27.25 |
| 2013-03-31 | 32.29 | $1.15 | 28.08 |
| 2012-12-31 | 27.76 | $0.99 | 28.04 |
| 2012-09-30 | 24.37 | $0.72 | 33.85 |
| 2012-06-30 | 22.53 | $0.39 | 57.77 |
| 2012-03-31 | 21.22 | $0.39 | 54.41 |
| 2011-12-31 | 17.11 | $0.38 | 45.03 |
| 2011-09-30 | 16.08 | $0.67 | 24.00 |
| 2011-06-30 | 23.56 | $1.04 | 22.65 |
| 2011-03-31 | 21.59 | $1.21 | 17.84 |
| 2010-12-31 | 21.90 | $1.44 | 15.21 |
| 2010-09-30 | 21.62 | $1.59 | 13.60 |
| 2010-06-30 | 28.89 | $1.66 | 17.40 |
| 2010-03-31 | 26.41 | $1.59 | 16.61 |
| 2009-12-31 | 21.73 | $1.57 | 13.84 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.316B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.316B | 26.95 |
| CVS Health (CVS) | United States | $75.446B | 9.38 |
| Elevance Health (ELV) | United States | $64.396B | 8.66 |
| Cencora (COR) | United States | $55.472B | 19.30 |
| DiDi Global (DIDIY) | China | $25.980B | 27.60 |
| Labcorp Holdings (LH) | United States | $21.919B | 17.30 |
| Natera (NTRA) | United States | $18.843B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.929B | 0.00 |
| CochLear (CHEOY) | Australia | $13.403B | 0.00 |
| Solventum (SOLV) | United States | $12.763B | 13.51 |
| Medpace Holdings (MEDP) | United States | $12.728B | 33.68 |
| Revvity (RVTY) | United States | $11.202B | 19.44 |
| Viatris (VTRS) | United States | $10.868B | 3.73 |
| Avantor (AVTR) | United States | $9.533B | 13.85 |
| Sonic Healthcare (SKHHY) | Australia | $9.208B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.791B | 17.23 |
| HealthEquity (HQY) | United States | $8.281B | 36.27 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.884B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.109B | 30.08 |
| BrightSpring Health Services (BTSG) | United States | $3.600B | 33.03 |
| Sotera Health (SHC) | United States | $3.489B | 19.82 |
| Surgery Partners (SGRY) | United States | $2.876B | 37.40 |
| Organon (OGN) | United States | $2.592B | 2.75 |
| Concentras Parent (CON) | United States | $2.576B | 14.89 |
| GeneDx Holdings (WGS) | United States | $2.423B | 93.31 |
| Alignment Healthcare (ALHC) | United States | $2.346B | 0.00 |
| Progyny (PGNY) | United States | $1.989B | 43.77 |
| PACS (PACS) | United States | $1.792B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.789B | 35.79 |
| Premier (PINC) | United States | $1.739B | 13.20 |
| Ardent Health (ARDT) | United States | $1.525B | 6.50 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.228B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.088B | 8.28 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.824B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.753B | 7.05 |
| CareDx (CDNA) | United States | $0.712B | 11.12 |
| Embecta (EMBC) | United States | $0.662B | 4.46 |
| Nutex Health (NUTX) | United States | $0.513B | 7.77 |
| So-Young (SY) | China | $0.513B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.506B | 0.00 |
| LifeMD (LFMD) | United States | $0.494B | 0.00 |
| Omada Health (OMDA) | $0.478B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.477B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.457B | 10.28 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.406B | 0.00 |
| Enhabit (EHAB) | United States | $0.344B | 28.29 |
| Oncology Institute (TOI) | United States | $0.336B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.286B | 0.00 |
| Beauty Health (SKIN) | United States | $0.222B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.204B | 0.00 |
| DocGo (DCGO) | United States | $0.152B | 24.83 |
| Sera Prognostics (SERA) | United States | $0.118B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| KindlyMD (NAKA) | United States | $0.077B | 0.00 |
| Biodesix (BDSX) | United States | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |